181 related articles for article (PubMed ID: 33881805)
1. Ultrasound-Enhanced Self-Exciting Photodynamic Therapy Based on Hypocrellin B.
Ding Y; Liu W; Wu J; Zheng X; Ge J; Ren H; Zhang W; Lee CS; Wang P
Chem Asian J; 2021 May; 16(10):1221-1224. PubMed ID: 33881805
[TBL] [Abstract][Full Text] [Related]
2. Hypocrellin B-based activatable photosensitizers for specific photodynamic effects against high H
Kitamura T; Nakata H; Takahashi D; Toshima K
Chem Commun (Camb); 2021 Dec; 58(2):242-245. PubMed ID: 34850796
[TBL] [Abstract][Full Text] [Related]
3. Hypocrellin Derivative-Loaded Calcium Phosphate Nanorods as NIR Light-Triggered Phototheranostic Agents with Enhanced Tumor Accumulation for Cancer Therapy.
Wang H; Jia Q; Liu W; Nan F; Zheng X; Ding Y; Ren H; Wu J; Ge J
ChemMedChem; 2020 Jan; 15(2):177-181. PubMed ID: 31755659
[TBL] [Abstract][Full Text] [Related]
4. Near-Infrared Hypocrellin Derivatives for Synergistic Photodynamic and Photothermal Therapy.
Ding Y; Liu W; Wu J; Zheng X; Ge J; Ren H; Zhang W; Lee CS; Wang P
Chem Asian J; 2020 Nov; 15(21):3462-3468. PubMed ID: 32909355
[TBL] [Abstract][Full Text] [Related]
5. Selenium-engineered covalent organic frameworks for high-efficiency and long-acting cancer therapy.
Wan X; Wu T; Song L; Pan W; Li N; Tang B
Chem Commun (Camb); 2021 Jun; 57(50):6145-6148. PubMed ID: 34042122
[TBL] [Abstract][Full Text] [Related]
6. Nanoscale Covalent Organic Framework for Combinatorial Antitumor Photodynamic and Photothermal Therapy.
Guan Q; Zhou LL; Li YA; Li WY; Wang S; Song C; Dong YB
ACS Nano; 2019 Nov; 13(11):13304-13316. PubMed ID: 31689082
[TBL] [Abstract][Full Text] [Related]
7. A small-sized and stable 2D metal-organic framework: a functional nanoplatform for effective photodynamic therapy.
Gao Z; Chen F; Li Y; Zhang Y; Cheng K; An P; Sun B
Dalton Trans; 2019 Dec; 48(45):16861-16868. PubMed ID: 31710076
[TBL] [Abstract][Full Text] [Related]
8. A novel hypocrellin-based assembly for sonodynamic therapy against glioblastoma.
Zhang C; Wu J; Liu W; Zheng X; Zhang W; Lee CS; Wang P
J Mater Chem B; 2021 Dec; 10(1):57-63. PubMed ID: 34842264
[TBL] [Abstract][Full Text] [Related]
9. External heavy-atomic construction of photosensitizer nanoparticles for enhanced in vitro photodynamic therapy of cancer.
Zhou L; Wei S; Ge X; Zhou J; Yu B; Shen J
J Phys Chem B; 2012 Oct; 116(42):12744-9. PubMed ID: 22984941
[TBL] [Abstract][Full Text] [Related]
10. Heparin-Coated Photosensitive Metal-Organic Frameworks as Drug Delivery Nanoplatforms of Autophagy Inhibitors for Sensitized Photodynamic Therapy against Breast Cancer.
Sun Q; Hou X; Yang J; Zhang M; Yang Y; Liu Y; Shen W; Yin D
ACS Appl Mater Interfaces; 2021 Nov; 13(46):55577-55590. PubMed ID: 34762394
[TBL] [Abstract][Full Text] [Related]
11. Quantitative and site-directed chemical modification of hypocrellins toward direct drug delivery and effective photodynamic activity.
Deng H; Liu X; Xie J; Yin R; Huang N; Gu Y; Zhao J
J Med Chem; 2012 Mar; 55(5):1910-9. PubMed ID: 22352922
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, characterization and photodynamic activity of phenmethylamino-demethoxy-hypocrellin B.
Xu S; Chen S; Zhang M; Shen T
J Photochem Photobiol B; 2003 Dec; 72(1-3):61-7. PubMed ID: 14644567
[TBL] [Abstract][Full Text] [Related]
13. Surface Decorated Porphyrinic Nanoscale Metal-Organic Framework for Photodynamic Therapy.
Kan JL; Jiang Y; Xue A; Yu YH; Wang Q; Zhou Y; Dong YB
Inorg Chem; 2018 May; 57(9):5420-5428. PubMed ID: 29664624
[TBL] [Abstract][Full Text] [Related]
14. New potential photodynamic therapeutic anti-cancer agents: synthesis and characterization of demethoxy amino-substituted hypocrellins.
Wu T; Xu S; Shen J; Song A; Chen S; Zhang M; Shen T
Anticancer Drug Des; 2000 Aug; 15(4):287-93. PubMed ID: 11200504
[TBL] [Abstract][Full Text] [Related]
15. Biophysical evaluation of two red-shifted hypocrellin B derivatives as novel PDT agents.
Paul BT; Babu MS; Santhoshkumar TR; Karunagaran D; Selvam GS; Brown K; Woo T; Sharma S; Naicker S; Murugesan R
J Photochem Photobiol B; 2009 Jan; 94(1):38-44. PubMed ID: 18977666
[TBL] [Abstract][Full Text] [Related]
16. A metal-organic cage-based nanoagent for enhanced photodynamic antitumor therapy.
Li WY; Zhao CW; Zhang YF; Guan Q; Wan JJ; Ma JP; Li YA; Dong YB
Chem Commun (Camb); 2021 Aug; 57(64):7954-7957. PubMed ID: 34286749
[TBL] [Abstract][Full Text] [Related]
17. Combination of chemotherapy and photodynamic therapy using graphene oxide as drug delivery system.
Zhou L; Zhou L; Wei S; Ge X; Zhou J; Jiang H; Li F; Shen J
J Photochem Photobiol B; 2014 Jun; 135():7-16. PubMed ID: 24792568
[TBL] [Abstract][Full Text] [Related]
18. Chemo-photodynamic antitumour therapy based on Er-doped upconversion nanoparticles coated with hypocrellin B and MnO
Lan J; Chen S; Chen Z; Luo D; Yu C; Zeng L; Sun W; Zhang X; Yao X; Wu F; Chen J
Biomater Adv; 2024 Jul; 161():213891. PubMed ID: 38781738
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, characterization and photodynamic activity of amino-substituted hypocrellin derivatives.
Tang YJ; Liu HY; An JY; Han R
Photochem Photobiol; 2001 Aug; 74(2):201-5. PubMed ID: 11547555
[TBL] [Abstract][Full Text] [Related]
20. A CuS- and BODIPY-loaded nanoscale covalent organic framework for synergetic photodynamic and photothermal therapy.
Dong XJ; Li WY; Guan Q; Li YA; Dong YB
Chem Commun (Camb); 2022 Feb; 58(14):2387-2390. PubMed ID: 35081192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
